Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT05337202

the Dutch-GERAF Study

Sponsor: Dijklander Ziekenhuis

View on ClinicalTrials.gov

Summary

Geriatric patients are at high risk of cardiovascular complications, and for the development of atrial fibrillation. Often atrial fibrillation exists in these patients without specific symptoms, and could therefore remain unknown. Furthermore, concerns exist about the bleeding profile of anticoagulation in the very elderly or frail patients. This study applies opportunistic screening for atrial fibrillation as advised in the latest ESC Guideline on the diagnosis and management of atrial fibrillation. Furthermore, multiple bleeding risk scores will be applies, to better assess the bleeding risk in very elderly or frail patients.

Official title: The Dutch Multicentre Study Into Opportunistically Screening Geriatric Patients for Atrial Fibrillation Using a PPG Smartphone App; the Dutch-GERAF Study

Key Details

Gender

All

Age Range

65 Years - Any

Study Type

OBSERVATIONAL

Enrollment

1075

Start Date

2021-01-25

Completion Date

2026-06-30

Last Updated

2024-02-20

Healthy Volunteers

No

Interventions

DEVICE

HeartSDK

The photoplethysmography (PPG) application enables patients to perform a finger tip heartbeat measurement and automatic analysis

Locations (6)

Rijnstate

Arnhem, Gelderland, Netherlands

Dijklander Ziekenhuis

Hoorn, North Holland, Netherlands

Noordwest ziekenhuisgroep

Alkmaar, Netherlands

Meander Medisch Centrum

Amersfoort, Netherlands

Onze Lieve Vrouwe Gasthuis

Amsterdam, Netherlands

Albert Schweitzer Ziekenhuis

Dordrecht, Netherlands